Editorial commentary on the special issue of Advances in Nanomedicine

Reimhult Erik; Misevic Gradimir

doi:10.7555/JBR.35.20210701

Volume 35 Issue 4

Jul. 2021

Turn off MathJax

Article Contents

Article Navigation > The Journal of Biomedical Research > 2021 > 35(4): 253-254

Reimhult Erik, Misevic Gradimir. Editorial commentary on the special issue of Advances in Nanomedicine[J]. The Journal of Biomedical Research, 2021, 35(4): 253-254. doi: 10.7555/JBR.35.20210701

Citation:

Reimhult Erik, Misevic Gradimir. Editorial commentary on the special issue of Advances in Nanomedicine[J]. The Journal of Biomedical Research, 2021, 35(4): 253-254. doi: 10.7555/JBR.35.20210701

Reimhult Erik, Misevic Gradimir. Editorial commentary on the special issue of Advances in Nanomedicine[J]. The Journal of Biomedical Research, 2021, 35(4): 253-254. doi: 10.7555/JBR.35.20210701

Citation:

Reimhult Erik, Misevic Gradimir. Editorial commentary on the special issue of Advances in Nanomedicine[J]. The Journal of Biomedical Research, 2021, 35(4): 253-254. doi: 10.7555/JBR.35.20210701

PDF( 1571 KB)

Editorial commentary on the special issue of Advances in Nanomedicine

doi: 10.7555/JBR.35.20210701

Reimhult Erik^{1
,
,},
Misevic Gradimir^{2
,
,}

1.
Department of Nanobiotechnology, Institute for Biologically Inspired Materials, University of Natural Resources and Life Sciences, Vienna, 1190 Vienna, Austria
2.
Research and Development, Gimmune GmbH, 6302 Zug, Switzerland

More Information

Corresponding author: Erik Reimhult, Department of Nanobiotechnology, Institute for Biologically Inspired Materials, University of Natural Resources and Life Sciences, Vienna, Muthgasse 11, 1190 Vienna, Austria. Tel/Fax: +43-1-47654-80211/+43-1-47891-12, E-mail: erik.reimhult@boku.ac.at; Gradimir Misevic, Research and Development, Gimmune GmbH, Baarerstrasse 12, 6302 Zug, Switzerland. Tel/Fax: +41-76-411-6243/+41-76-411-6243, E-mail: gradimir@gimmune.com
Received: 2021-05-10
Accepted: 2021-05-10

Published: 2021-05-17

Issue Date: 2021-07-28

Abstract

FullText(HTML)

References(9)

References

[1]	Gheorghiu M. A short review on cell-based biosensing: challenges and breakthroughs in biomedical analysis[J]. J Biomed Res. doi: 10.7555/JBR.34.20200128
[2]	Gradimir M. Single-cell omics analyses with single molecular detection: challenges and perspectives[J]. J Biomed Res. doi: 10.7555/JBR.35.20210026
[3]	Gheorghiu E. Detection of pathogenic bacteria by magneto-immunoassays: a review[J]. J Biomed Res. doi: 10.7555/JBR.34.20200123
[4]	Liu X, Nakamura F. Mechanotransduction, nanotechnology, and nanomedicine[J]. J Biomed Res. doi: 10.7555/JBR.34.20200063
[5]	Svistunenko DA. EPR spectroscopy of whole blood and blood components: can we diagnose abnormalities?[J]. J Biomed Res. doi: 10.7555/JBR.35.20210011
[6]	Reimhult E, Virk MM. Hybrid lipopolymer vesicle drug delivery and release systems[J]. J Biomed Res. doi: 10.7555/JBR.35.20200206
[7]	Barja F. Bacterial nanocellulose production and biomedical applications[J]. J Biomed Res. doi: 10.7555/JBR.35.20210036
[8]	Wang S, Jiang H, Wang J, et al. Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer[J]. J Biomed Res. doi: 10.7555/JBR.35.20210102.
[9]	Zhang J, Sun H, Pei W, et al. Nanobody-based immunosensing methods for safeguarding public health[J]. J Biomed Res. doi: 10.7555/JBR.35.20210108.